Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kapusta

Showing results (921-930 of 1,027) with videos related to

Pageof 103
Sort By:
Circulation. Cardiovascular Genetics|May 17, 2013
The cardiac phenotype in patients with a CHD7 mutationNicole Corsten-Janssen, Wilhelmina S Kerstjens-Frederikse, Gideon J du Marchie Sarvaas, et al.
JACC. Cardiooncology|August 16, 2021
Cardiac Disease in Childhood Cancer Survivors: Risk Prediction, Prevention, and Surveillance: <i>JACC CardioOncology</i> State-of-the-Art ReviewJan M Leerink, Esmée C de Baat, Elizabeth A M Feijen, et al.
Journal of Medical Genetics|September 13, 2005
CHARGE syndrome: the phenotypic spectrum of mutations in the CHD7 geneM C J Jongmans, R J Admiraal, K P van der Donk, et al.
Journal of Medical Genetics|October 24, 2007
A novel mitochondrial ATP8 gene mutation in a patient with apical hypertrophic cardiomyopathy and neuropathyA I Jonckheere, M Hogeveen, L G J Nijtmans, et al.
Plos Genetics|January 14, 2012
Autosomal recessive dilated cardiomyopathy due to DOLK mutations results from abnormal dystroglycan O-mannosylationDirk J Lefeber, Arjan P M de Brouwer, Eva Morava, et al.
Rheumatology (Oxford, England)|February 6, 2009
Evaluation of the clinimetric properties of the Early Inflammatory Arthritis--self-administered comorbidity questionnaireMurray Baron, Orit Schieir, Marie Hudson, et al.
The Lancet. Child & Adolescent Health|September 29, 2022
Primary cardioprotection with dexrazoxane in patients with childhood cancer who are expected to receive anthracyclines: recommendations from the International Late Effects of Childhood Cancer Guideline Harmonization GroupEsmée C de Baat, Elvira C van Dalen, Renée L Mulder, et al.
Journal of Immunological Methods|July 29, 2008
Functional C1-inhibitor diagnostics in hereditary angioedema: assay evaluation and recommendationsIneke G A Wagenaar-Bos, Christian Drouet, Emel Aygören-Pursun, et al.
Heart (British Cardiac Society)|August 31, 2018
Biomarkers to diagnose ventricular dysfunction in childhood cancer survivors: a systematic reviewJan M Leerink, Simone J Verkleij, Elizabeth A M Feijen, et al.
JACC. Cardiooncology|June 21, 2025
IGHG Recommendations for Anthracycline and Anthraquinone Cardiac Dysfunction Equivalence Ratios After Childhood Cancer: JACC: CardioOncology Expert PanelTheodorus W Kouwenberg, Elvira C van Dalen, Renée L Mulder, et al.
Pageof 103

Showing results (921-930 of 1,027) with videos related to

Sort By:
Pageof 103
Circulation. Cardiovascular Genetics|May 17, 2013
The cardiac phenotype in patients with a CHD7 mutationNicole Corsten-Janssen, Wilhelmina S Kerstjens-Frederikse, Gideon J du Marchie Sarvaas, et al.
JACC. Cardiooncology|August 16, 2021
Cardiac Disease in Childhood Cancer Survivors: Risk Prediction, Prevention, and Surveillance: <i>JACC CardioOncology</i> State-of-the-Art ReviewJan M Leerink, Esmée C de Baat, Elizabeth A M Feijen, et al.
Journal of Medical Genetics|September 13, 2005
CHARGE syndrome: the phenotypic spectrum of mutations in the CHD7 geneM C J Jongmans, R J Admiraal, K P van der Donk, et al.
Journal of Medical Genetics|October 24, 2007
A novel mitochondrial ATP8 gene mutation in a patient with apical hypertrophic cardiomyopathy and neuropathyA I Jonckheere, M Hogeveen, L G J Nijtmans, et al.
Plos Genetics|January 14, 2012
Autosomal recessive dilated cardiomyopathy due to DOLK mutations results from abnormal dystroglycan O-mannosylationDirk J Lefeber, Arjan P M de Brouwer, Eva Morava, et al.
Rheumatology (Oxford, England)|February 6, 2009
Evaluation of the clinimetric properties of the Early Inflammatory Arthritis--self-administered comorbidity questionnaireMurray Baron, Orit Schieir, Marie Hudson, et al.
The Lancet. Child & Adolescent Health|September 29, 2022
Primary cardioprotection with dexrazoxane in patients with childhood cancer who are expected to receive anthracyclines: recommendations from the International Late Effects of Childhood Cancer Guideline Harmonization GroupEsmée C de Baat, Elvira C van Dalen, Renée L Mulder, et al.
Journal of Immunological Methods|July 29, 2008
Functional C1-inhibitor diagnostics in hereditary angioedema: assay evaluation and recommendationsIneke G A Wagenaar-Bos, Christian Drouet, Emel Aygören-Pursun, et al.
Heart (British Cardiac Society)|August 31, 2018
Biomarkers to diagnose ventricular dysfunction in childhood cancer survivors: a systematic reviewJan M Leerink, Simone J Verkleij, Elizabeth A M Feijen, et al.
JACC. Cardiooncology|June 21, 2025
IGHG Recommendations for Anthracycline and Anthraquinone Cardiac Dysfunction Equivalence Ratios After Childhood Cancer: JACC: CardioOncology Expert PanelTheodorus W Kouwenberg, Elvira C van Dalen, Renée L Mulder, et al.
Pageof 103